Clinical Trial Update: 2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients. [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial compared two ferric sucrose (Ferrlecit) dosing regimens to oral iron for treating iron-deficiency anemia in peritoneal dialysis patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• FERRLECIT (SODIUM FERRIC GLUCONATE COMPLEX)
• Ferrous sulfate (oral iron) (ferrous sulfate)

Snippet

Sponsor: Watson Pharmaceuticals | Conditions: Iron Deficiency Anemia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2009-09-28